Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma

被引：0
|
作者：
Kevin B. Kim
Wen-Jen Hwu
Nicholas E. Papadopoulos
Agop Y. Bedikian
Luis H. Camacho
Chaan Ng
Ingrid M. Hernandez
Angela M. Frost
Monica A. Jack
Patrick Hwu
机构：
[1] The University of Texas M. D. Anderson Cancer Center,Department of Melanoma Medical Oncology, Unit 430
[2] The University of Texas M. D. Anderson Cancer Center,Department of Diagnostic Radiology
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Phase I; Melanoma; Chemotherapy; Docetaxel; Temozolomide; Cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：161 / 167
页数：6
相关论文
共 50 条
  • [1] Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
    Kim, Kevin B.
    Hwu, Wen-Jen
    Papadopoulos, Nicholas E.
    Bedikian, Agop Y.
    Camacho, Luis H.
    Ng, Chaan
    Hernandez, Ingrid M.
    Frost, Angela M.
    Jack, Monica A.
    Hwu, Patrick
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 161 - 167
  • [2] Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial
    Tas, F
    Argon, A
    Camlica, H
    Topuz, E
    MELANOMA RESEARCH, 2005, 15 (06) : 543 - 548
  • [3] A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma
    McQuade, Jennifer L.
    Posada, Liberty P.
    Lecagoonporn, Srisuda
    Cain, Suzanne
    Bassett, Roland L., Jr.
    Patel, Sapna P.
    Hwu, Wen-Jen
    Hwu, Patrick
    Davies, Michael A.
    Bedikian, Agop Y.
    Amaria, Rodabe N.
    MELANOMA RESEARCH, 2016, 26 (06) : 604 - 608
  • [4] Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial
    Wierzbicka-Hainaut, Ewa
    Sassolas, Bruno
    Mourey, Laurent
    Guillot, Bernard
    Bedane, Christophe
    Guillet, Gerard
    Tourani, Jean Marc
    MELANOMA RESEARCH, 2010, 20 (02) : 141 - 146
  • [5] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
    Park, Keon Woo
    Ahn, Jin Seok
    Park, Young Suk
    Lee, Jeeyun
    Kang, Jung Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Im, Young-Hyuck
    Kang, Won Ki
    Park, Keunchil
    Lee, Soon Il
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 17 - 21
  • [6] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
    Keon Woo Park
    Jin Seok Ahn
    Young Suk Park
    Jeeyun Lee
    Jung Hoon Kang
    Joon Oh Park
    Ho Yeong Lim
    Young-Hyuck Im
    Won Ki Kang
    Keunchil Park
    Soon Il Lee
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 17 - 21
  • [7] A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma
    Pettijohn, Erin
    Martone, Brenda
    Rademaker, Alfred
    Kuzel, Timothy
    JOURNAL OF PERSONALIZED MEDICINE, 2014, 4 (04) : 448 - 458
  • [8] The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma
    Yoon, Chan
    Papadopoulos, Nicholas E.
    Camacho, Luis H.
    McIntyre, Susan
    Alvarado, Gladys C.
    Bedikian, Agop Y.
    Hwu, Patrick
    Kim, Kevin B.
    MELANOMA RESEARCH, 2010, 20 (01) : 43 - 47
  • [9] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    British Journal of Cancer, 2007, 97 : 851 - 856
  • [10] Temozolomide in combination with fotemustine in patients with metastatic melanoma
    Faruk Tas
    Hakan Camlica
    Erkan Topuz
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 293 - 298
12345